Trials / Completed
CompletedNCT00168233
Impact of HIV and Its Treatment on Reverse Cholesterol Transport
Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- The Alfred · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of treatment of HIV infection with highly active antiretroviral therapy on individual steps of reverse cholesterol transport, endothelial function and intima-media thickness in HIV patients.
Conditions
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2010-09-01
- Completion
- 2011-03-01
- First posted
- 2005-09-15
- Last updated
- 2012-01-20
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00168233. Inclusion in this directory is not an endorsement.